Radiation Dermatitis Clinical Trial
Official title:
Skin Protection During Radiotherapy in Patients With Breast Cancer: A Comparative Study of Evoskin® Verus Trixéra®
Radiotherapy may cause severe skin changes that significantly interfere with the patient's quality of life and may reduce radiotherapy effectiveness. Many skin care instructions and various topical agents are recommended to help patients in the management of radiation skin reactions, but evidence to support the value of the topical treatments of the irradiated skin is lacking. In the present study we investigated the effects of two topical agents used as supportive care to protect skin during radiotherapy.
Women with breast cancer and were to receive breast radiotherapy to 50 Gy were enrolled in a prospective randomized trial to compare the effectiveness of Evoskin®) for protecting skin compared to Trixiera. To account for individual differences in radiation each subject served as her own control, as each was to apply the experimental and control agents to the irradiated breast. Each patient was randomly assigned to use Evoskin on the half of the irradiated breast and to use the Triexiera on the other half. Dermatitis was graded weekly by means of a spectrophotometer. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04059809 -
Photobiomodulation for Breast Cancer Radiodermatitis
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT06040983 -
Clinical Investigation on the Treatment of Radiation Induced Dermatitis With FR-101 Chest Dressing
|
N/A | |
Withdrawn |
NCT05505214 -
Topical Steroids & Bacterial Decolonization for Radiation Dermatitis
|
Phase 2 | |
Withdrawn |
NCT04593914 -
A Novel Skin Barrier Protectant for Acute Radiodermatitis
|
N/A | |
Completed |
NCT05450848 -
StrataXRT vs. Standard Clinical Practice in the Prevention and Treatment of Radiation Dermatitis
|
N/A | |
Active, not recruiting |
NCT05594498 -
A Study of StrataXRT in the Prevention of Radiation Dermatitis in Breast Cancer Patients
|
N/A | |
Recruiting |
NCT04110977 -
A Reminder App to Reduce Radiation Dermatitis Rates in Patients With Head-and-Neck Cancer
|
N/A | |
Recruiting |
NCT06158347 -
Efficacy and Safety of Hyperbaric Oxygen Therapy for Radiation Dermatitis in Patients With Localized Breast Cancer
|
N/A | |
Recruiting |
NCT05553392 -
StrataXRT Versus Aquaphor for the Prevention and Management of Radiation Dermatitis
|
N/A | |
Active, not recruiting |
NCT04268056 -
Characterization of Skin Microbiome Profile and it's Correlation to Radiation Dermatitis
|
||
Not yet recruiting |
NCT04888234 -
Evaluation the Effectiveness of Ru-Yi-Jin-Huang Powder for the Radiation-induced Dermatitis.
|
Phase 2 | |
Terminated |
NCT01597921 -
A DB Randomized Study of R1 and R2 WaterJel / AloeVera Jell in Prevention of Radiation Dermatitis in Breast Cancer
|
N/A | |
Completed |
NCT00481884 -
Comparing RadiaPlexRx Hydrogel and Standard-of-Care for Radiation Dermatitis in Breast Cancer Patients
|
Phase 3 | |
Completed |
NCT03494205 -
Urtica Comp. Gel for Prevention and Therapy of Radiation Dermatitis
|
Phase 2 | |
Completed |
NCT05810194 -
Retrospective Cohort Study Comparing a Novel Gel Dressing vs SoC in the Treatment of Radiation Dermatitis
|
||
Completed |
NCT03941665 -
Use of Gelronate Gel vs. Aloevera in Preventing/Minimizing Radiation-induced Dermatitis in Breast Cancer Patients
|
N/A | |
Not yet recruiting |
NCT02051907 -
Clinical Study to Evaluate Safety and Efficacy of KAM1403 Gel to Treat Radiation Dermatitis
|
Phase 2 | |
Completed |
NCT02839473 -
Hydrosorb® Versus Control in the Management of Radio-induced Skin Toxicity: Multicentre Controlled Phase III Randomized Trial
|
Phase 3 | |
Completed |
NCT00876642 -
Trial Comparing Best Supportive Care to Aloe Vera Gel
|
Phase 3 | |
Completed |
NCT00573365 -
LED Photomodulation for Prevention of Post-Radiation Treatment Dermatitis
|
N/A |